Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Artemether-Lumefantrine for Uncomplicated Malaria in Niger
NCT05070520Phase 4Completed
- Sponsor
- Programme National de Lutte contre le Paludisme
- Start
- Sep 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of artemether + lumefantrine in Plasmodium falciparum malaria, sponsored by Programme National de Lutte contre le Paludisme. Started Sep 2020; status: completed.
02
Drugs
artemether + lumefantrine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT05070520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05070520.